Geneos Wealth Management’s Strive Emerging Markets ex-China ETF STXE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.82K Hold
200
﹤0.01% 2052
2025
Q4
$7.18K Hold
200
﹤0.01% 2055
2025
Q3
$6.58K Hold
200
﹤0.01% 2080
2025
Q2
$6.2K Sell
200
-200
-50% -$5.76K ﹤0.01% 2503
2025
Q1
$10.9K Buy
400
+200
+100% +$5.55K ﹤0.01% 2543
2024
Q4
$5.51K Buy
+200
New +$5.86K ﹤0.01% 2296

Other funds holding STXE

Geneos Wealth Management's STXE Position: Q1 2026 in Review

Geneos Wealth Management held its Strive Emerging Markets ex-China ETF (STXE) position steady in Q1 2026 at 200 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Geneos Wealth Management first reported a position in STXE in Q4 2024 and has held it in 6 quarters since. The position peaked at $10.9K in Q1 2025. 37 funds tracked by Wall St. Rank hold STXE as of Q1 2026.

  • Geneos Wealth Management held 200 shares of Strive Emerging Markets ex-China ETF worth $7.82K as of Q1 2026.
  • Geneos Wealth Management left its Strive Emerging Markets ex-China ETF share count unchanged in Q1 2026.
  • Strive Emerging Markets ex-China ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2052 holding.
  • Geneos Wealth Management first reported a position in Strive Emerging Markets ex-China ETF in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's Strive Emerging Markets ex-China ETF position peaked at $10.9K in Q1 2025.
  • 37 funds tracked by Wall St. Rank held Strive Emerging Markets ex-China ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.